Merrimack Pharmaceuticals

$3.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.05 (+1.34%) Today
$0.00 (0.00%) As of 12:09 PM UTC after-hours

Why Robinhood?

You can buy or sell MACK and other stocks, options, and ETFs commission-free!

About MACK

Merrimack Pharmaceuticals, Inc. Common Stock, also called Merrimack Pharmaceuticals, is a clinical stage biopharmaceutical company, which engages in discovering, developing, and commercializing medicines consisting of novel therapeutics paired with diagnostics for the treatment of cancer. Its pipeline includes MM-131, MM-141, and MM-310. The company was founded by Anthony J. Sinskey, Gavin MacBeath, and Ulrik B. Nielsen in 1993 and is headquartered in Cambridge, MA. The listed name for MACK is Merrimack Pharmaceuticals, Inc. Common Stock.

CEO
Gary L. Crocker
Employees
Headquarters
Cambridge, Massachusetts
Founded
1993
Market Cap
50.44M
Price-Earnings Ratio
Dividend Yield
13.46
Average Volume
58.21K
High Today
$3.84
Low Today
$3.73
Open Price
$3.73
Volume
55.72K
52 Week High
$4.75
52 Week Low
$1.49

Collections

MACK Earnings

-$0.78
-$0.51
-$0.25
$0.02
Q1 FY19
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
per share
Actual
Expected Mar 11, After Hours

You May Also Like